Coronavirus Essential | India's Covaxin may enter phase 3 trials in October; Bharat Biotech to make billion doses of intranasal vaccines

Headliner Embed

Embed code See more options

Share

Facebook X

Subscribe

Tune in to the Coronavirus Essential podcast for the top news on the pandemic.

Share

Facebook X

Subscribe

Next

Hot Stocks | OFSS a buy call for short term; sell on HDFC Bank, Ambuja Cements

Top episodes

The Market Podcast | Why Airtel rose despite AGR setback and what to do with DMart, Yes Bank and IRCTC

by Moneycontrol Podcast

Interview | Ramesh Damani's thumb rule of 24% returns can make you really rich

by Moneycontrol Podcast

Coronavirus Essential | PM Modi’s lights out, light up message; lockdown may continue until September, says study

by Moneycontrol Podcast

•   Report this episode
•   Download audio
•   QRCode